This session will explore future FDA regulatory stance upon the hemp industry, way to prepare operations for GMP compliance and protect intellectual property
Strategic Advisor - Backbone IQ
The future of FDA regulation and GMP manufacturing
About Peter Holzworth
Peter Holzworth has been a professional in the compliance and legal aspects of the cannabis industry since 2014. Recently serving as Director of Cannabis Client services at the fortune 500 law firm of Zuber Lawler, he was a key member of the team that achieved the first ever cannabinoid plant patent, first New Dietary Ingredient (NDI) and Generally Recognized As Safe (GRAS). He has consulted for varies state governments and sovereign nations upon regulatory formation of legal cannabis and hemp industries.